Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement
NCT01270620 is a phase 4 interventional trial sponsored by Pedro Paulo Tanaka. As of 18 Nov 2026, it is completed. It studies Desflurane and Propofol in Arthritis and Obesity. The registry lists an enrollment of 100 participants at 1 site in 1 country. The registry lists a start date of 31 Dec 2010 and a primary completion date of 31 Jul 2015.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01270620 |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | Pedro Paulo Tanaka |
| Enrollment | 100 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Arthritis and Obesity |
| Drugs | Desflurane and Propofol |
| Start | 31 Dec 2010 |
| Primary completion | 31 Jul 2015 |
| Study completion | 31 Jul 2015 |
| Last update posted | 22 Oct 2015 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Hendrikus Lemmens
Stanford University
Principal Investigator - Pedro Paulo Tanaka
Stanford University
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University School of Medicine
Stanford
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT01270620
Each answer restates registry values shown on this page.
What is NCT01270620?
NCT01270620 is a phase 4 interventional trial sponsored by Pedro Paulo Tanaka. It studies Desflurane and Propofol in Arthritis and Obesity.
Who leads NCT01270620?
The registry names Hendrikus Lemmens (principal investigator, Stanford University) and Pedro Paulo Tanaka (study director, Stanford University) as overall officials.
Where does NCT01270620 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT01270620 study?
The registered drug and biological interventions are Desflurane and Propofol.
When did NCT01270620 end?
The registry lists a primary completion date of 31 Jul 2015 and a study completion date of 31 Jul 2015. The sponsor last updated the record on 22 Oct 2015.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.